TheProfitWatch

ALGS - Aligos Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.0 1.1 (13.69%) --- 0.06 (0.61%) 0.32 (3.59%) 0.01 (0.12%) 0.73 (8.66%) --- 0.01 (0.12%)

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.53
Diluted EPS:
-1.53
Basic P/E:
-5.9444
Diluted P/E:
-5.9444
RSI(14) 1m:
98.46
VWAP:
9.09
RVol:

Events

Period Kind Movement Occurred At

Related News